|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention provides methods for treating cancer using specific compounds.
|
|
gptkbp:activeDuring
|
Compound X
|
|
gptkbp:applicationNumber
|
10/2003,123,456
|
|
gptkbp:applicationPublicationNumber
|
gptkb:US_2003/0123456_A1
|
|
gptkbp:applicationStatus
|
abandoned
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:clinicalTrials
|
Study A
NCT01234567
|
|
gptkbp:composedOf
|
chemical synthesis method.
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:description
|
This patent describes novel compounds for cancer treatment.
|
|
gptkbp:dosageForm
|
tablet
|
|
gptkbp:evaluates
|
high
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
March 15, 2022
|
|
gptkbp:fieldOfInvention
|
pharmaceutical compositions
|
|
gptkbp:fieldOfUse
|
oncology
|
|
gptkbp:filingDate
|
March 15, 2002
|
|
gptkbp:formulation
|
oral solution
|
|
gptkbp:future_plans
|
Phase II
|
|
gptkbp:grantDate
|
September 14, 2004
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,249 C8
|
|
gptkbp:internationalClassification
|
A61K 31/00
|
|
gptkbp:inventor
|
gptkb:Alice_Johnson
gptkb:John_Doe
|
|
gptkbp:issuedOn
|
September 14, 2004
|
|
gptkbp:legalStatus
|
granted
|
|
gptkbp:maintenanceFee
|
paid
|
|
gptkbp:mandates
|
breast cancer
|
|
gptkbp:marketedAs
|
Brand Y
|
|
gptkbp:nonPatentCitation
|
Journal_of_Cancer_Research,_2001.
|
|
gptkbp:patentCitation
|
gptkb:US_5,123,456_A
|
|
gptkbp:patentExpiration
|
2024-03-15
|
|
gptkbp:patentFamily
|
US_6,789,249_C8_family
|
|
gptkbp:patentInventor
|
20 years
|
|
gptkbp:patentLitigation
|
Case 12345
|
|
gptkbp:patentNumber
|
6,789,249
|
|
gptkbp:patentOffice
|
gptkb:USPTO
|
|
gptkbp:patentType
|
granted patent
|
|
gptkbp:priorityDate
|
March 15, 2001
|
|
gptkbp:relatedPatent
|
gptkb:US_6,789,250_C8
|
|
gptkbp:relatedTo
|
cancer treatment
|
|
gptkbp:research_areas
|
oncology
treatment of tumors
|
|
gptkbp:researchField
|
biotechnology
|
|
gptkbp:researchInterest
|
gptkb:XYZ_Pharmaceuticals
|
|
gptkbp:route
|
oral
|
|
gptkbp:safetyFeatures
|
well tolerated
|
|
gptkbp:status
|
active
|
|
gptkbp:subclass
|
A61P 35/00
|
|
gptkbp:title
|
Compositions and methods for treating cancer
|